JP2002525081A5 - - Google Patents

Download PDF

Info

Publication number
JP2002525081A5
JP2002525081A5 JP2000571058A JP2000571058A JP2002525081A5 JP 2002525081 A5 JP2002525081 A5 JP 2002525081A5 JP 2000571058 A JP2000571058 A JP 2000571058A JP 2000571058 A JP2000571058 A JP 2000571058A JP 2002525081 A5 JP2002525081 A5 JP 2002525081A5
Authority
JP
Japan
Prior art keywords
polynucleotide
sequence
seq
antibody
polypeptide encoded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000571058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002525081A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/020394 external-priority patent/WO2000012525A1/en
Publication of JP2002525081A publication Critical patent/JP2002525081A/ja
Publication of JP2002525081A5 publication Critical patent/JP2002525081A5/ja
Pending legal-status Critical Current

Links

JP2000571058A 1998-08-27 1999-08-27 低酸素により調節される遺伝子転写に特徴的な配列 Pending JP2002525081A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9815898P 1998-08-27 1998-08-27
US60/098,158 1998-08-27
US13268499P 1999-05-05 1999-05-05
US60/132,684 1999-05-05
PCT/US1999/020394 WO2000012525A1 (en) 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription

Publications (2)

Publication Number Publication Date
JP2002525081A JP2002525081A (ja) 2002-08-13
JP2002525081A5 true JP2002525081A5 (ru) 2006-10-12

Family

ID=26794273

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000571058A Pending JP2002525081A (ja) 1998-08-27 1999-08-27 低酸素により調節される遺伝子転写に特徴的な配列
JP2000567249A Pending JP2002523072A (ja) 1998-08-27 1999-08-27 低酸素症調節遺伝子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2000567249A Pending JP2002523072A (ja) 1998-08-27 1999-08-27 低酸素症調節遺伝子

Country Status (6)

Country Link
EP (2) EP1115733A4 (ru)
JP (2) JP2002525081A (ru)
AU (1) AU5810999A (ru)
CA (2) CA2341705A1 (ru)
IL (2) IL141660A0 (ru)
WO (2) WO2000012139A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ.ヴイ. 電気的筋肉制御装置
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
EP1343912A2 (en) * 2000-11-28 2003-09-17 Wyeth Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
DE60237406D1 (de) * 2001-05-31 2010-09-30 Chiba Prefecture Aus einem Neuroblastom isolierte Nukleinsäuren
AU2002324451A1 (en) * 2001-06-21 2003-01-08 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
AU2003284357A1 (en) * 2002-11-01 2004-06-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
EP1670425A4 (en) * 2003-10-07 2008-04-16 Quark Pharmaceuticals Inc BONE MORPHOGENETIC PROTEIN (BMP) 2A AND ITS APPLICATIONS
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
JP2013220090A (ja) * 2012-04-19 2013-10-28 Tohoku Univ 眼疾患治療に使用する薬剤スクリーニング方法
AU2017368050A1 (en) 2016-11-29 2019-06-20 Puretech Lyt, Inc. Exosomes for delivery of therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000353A1 (en) 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product
US5731294A (en) * 1993-07-27 1998-03-24 Hybridon, Inc. Inhibition of neovasularization using VEGF-specific oligonucleotides
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases

Similar Documents

Publication Publication Date Title
JP2002525081A5 (ru)
JP2004504063A5 (ru)
JP2004511430A5 (ru)
JP2003522514A5 (ru)
JP2002527052A5 (ru)
JP2008538183A5 (ru)
JP2004525922A5 (ru)
JP2008525033A5 (ru)
JP2002508183A5 (ru)
JP2001514858A5 (ru)
RU2006144093A (ru) Полипептиды нетипируемой haemophilus influenzae
JP2002508970A5 (ru)
EP1347730A4 (en) RECOMBINANT ANTI-CD30 ANTIBODIES AND THEIR USES
JP2002505841A5 (ru)
JP2004517611A5 (ru)
JP2002503495A5 (ru)
JP2004518624A5 (ru)
JP2004504032A5 (ru)
JP2009520758A5 (ru)
EP1960426A4 (en) NEW NEUROTROPHIC FACTOR AND USES THEREOF
NZ607886A (en) Nogo receptor binding protein
CA2332570A1 (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
JP2003525623A5 (ru)
JP2003534287A5 (ru)
JP2002532079A5 (ru)